PRINCETON, N.J., Nov. 15, 2017 /PRNewswire/ -- Promius Pharma LLC announced today that ZEMBRACE ® SymTouch ® (sumatriptan injection) 3 mg, an acute migraine headache treatment on the market since ...
Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...
Q. I have had chronic migraines for over 18 years. To treat them, I have used most of the triptan migraine meds with varying degrees of success, along with Botox, Cambria and injectable Imitrex. I was ...
MUMBAI, Feb 17 (Reuters) - Drug firm Wockhardt Ltd on Tuesday said it will be launching Sumatriptan injections in the U.S. following following final approval from the U.S. Food & Drug Administration.
DEAR PEOPLE’S PHARMACY: I have had chronic migraines for over 18 years. To treat them, I have used most of the triptan migraine meds with varying degrees of success, along with Botox, Cambria and ...
Although generic formulations of sumatriptan are available, managed care companies are comparing Zecuity to GlaxoSmithKline plc's injectable Imitrex at approximately $95 per dose, according to Anido, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results